The ascension of Sildenafil initially fueled significant growth in the pharmaceutical sector, creating a understanding of easy returns. However, placing capital in companies heavily reliant on flagship drugs like https://safababl872011.qodsblog.com/41274410/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment